But the icing on the cake for the Cox-2 inhibiter saga came on December 2, 2005, when Gooz News ran an article titled, "Pricey Pain Pills No Better at Reducing Tummy Distress."
"It looks like the billions spent on expensive new Cox-2 inhibitors," Gooz said, "was wasted -- and not just because Vioxx was the likely cause of tens of thousands of heart attacks among its users."
Citing a report in the British Medical Journal that day, Gooz said that "Cox-2 inhibitors do not reduce the gastrointestinal side effects of over-the-counter pain pills like ibuprofen."
"This was the whole rationale for justifying the drug industry's massive investment in this new class of medicines," Gooz noted, "since they don't reduce pain any more effectively than older pain pills."
Information for injured parties can be found at Lawyers and Settlements
http://www.lawyersandsettlements.com/articles/pfizer.html
By Evelyn Pringle
"It looks like the billions spent on expensive new Cox-2 inhibitors," Gooz said, "was wasted -- and not just because Vioxx was the likely cause of tens of thousands of heart attacks among its users."
Citing a report in the British Medical Journal that day, Gooz said that "Cox-2 inhibitors do not reduce the gastrointestinal side effects of over-the-counter pain pills like ibuprofen."
"This was the whole rationale for justifying the drug industry's massive investment in this new class of medicines," Gooz noted, "since they don't reduce pain any more effectively than older pain pills."
http://www.lawyersandsettlements.com/articles/pfizer.html
By Evelyn Pringle
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
